A case of ramucirumab-related gastrointestinal perforation in gastric cancer with small bowel metastasis

BACKGROUND: Ramucirumab is a monoclonal antibody targeting vascular endothelial growth factor receptor 2 (VEGFR-2). Ramucirumab either alone or in combination with paclitaxel (PTX) has been found to be safe and effective for patients with previously treated advanced gastric cancer. One of the seriou...

Full description

Saved in:
Bibliographic Details
Published in:Surg Case Rep
Main Authors: Urakawa, Shinya, Sakai, Daisuke, Miyazaki, Yasuhiro, Kudo, Toshihiro, Katou, Aya, Inagaki, Chiaki, Tanaka, Koji, Makino, Tomoki, Takahashi, Tsuyoshi, Kurokawa, Yukinori, Yamasaki, Makoto, Nakajima, Kiyokazu, Takiguchi, Shuji, Satoh, Taroh, Mori, Masaki, Doki, Yuichiro
Format: Artigo
Language:Inglês
Published: Springer Berlin Heidelberg 2017
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5736507/
https://ncbi.nlm.nih.gov/pubmed/29260338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40792-017-0399-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items